These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9396396)

  • 21. [Immunohistochemical study of tissue polypeptide antigen (TPA) in human urinary bladder tumors].
    Kaneko K; Suzuki T; Takasaki E
    Nihon Hinyokika Gakkai Zasshi; 1989 Oct; 80(10):1430-5. PubMed ID: 2601216
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Role of tissue polypeptide antigen as a marker in bladder cancer].
    Menéndez V; Filella X; Alcover J; Molina R; Ballesta AM; Carretero P
    Actas Urol Esp; 1995 Jun; 19(6):441-4. PubMed ID: 8571803
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A study of urinary TPA in bladder cancer].
    Akagi T
    Nihon Hinyokika Gakkai Zasshi; 1988 Aug; 79(8):1337-47. PubMed ID: 3246818
    [No Abstract]   [Full Text] [Related]  

  • 24. [Evaluation of serum tissue polypeptide antigen (TPA) in patients with urogenital cancer].
    Tozuka K; Yonese Y; Nakagami Y; Minowa T; Hiraoka Y; Yamada N; Hikima N; Ishii Y; Tannowa K; Fujioka Y
    Gan To Kagaku Ryoho; 1984 May; 11(5):1078-83. PubMed ID: 6721513
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical studies on the measurement of urinary tissue polypeptide antigen (TPA) levels using Prolifigen TPA kit "Daiichi"-II in urothelial cancers].
    Ohmori H; Ohashi T; Aso Y; Kumamoto Y; Hisazumi H; Shiraiwa Y; Kurita T; Shimazaki J; Ohkawa T; Ogawa H
    Hinyokika Kiyo; 1988 Dec; 34(12):2101-10. PubMed ID: 3071123
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Independent prognostic value of serum hepatocyte growth factor in bladder cancer.
    Gohji K; Nomi M; Niitani Y; Kitazawa S; Fujii A; Katsuoka Y; Nakajima M
    J Clin Oncol; 2000 Aug; 18(16):2963-71. PubMed ID: 10944129
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intensive risk-adjusted follow-up with the CEA, TPA, CA19.9, and CA72.4 tumor marker panel and abdominal ultrasonography to diagnose operable colorectal cancer recurrences: effect on survival.
    Nicolini A; Ferrari P; Duffy MJ; Antonelli A; Rossi G; Metelli MR; Fulceri F; Anselmi L; Conte M; Berti P; Miccoli P
    Arch Surg; 2010 Dec; 145(12):1177-83. PubMed ID: 21173292
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Diagnostic value of tissue polypeptide antigen in serum of larynx cancer patients].
    Polberg K; Stepulak A; Stryjecka-Zimmer M; Kupisz K; Zawiślak J
    Pol Merkur Lekarski; 2005 Oct; 19(112):517-20. PubMed ID: 16379315
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of predictive markers for patients with advanced colorectal cancer.
    Byström P; Berglund Å; Nygren P; Wernroth L; Johansson B; Larsson A; Glimelius B
    Acta Oncol; 2012 Sep; 51(7):849-59. PubMed ID: 22974092
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urinary levels of tumour associated antigens (CA 19-9, TPA and CEA) in patients with neoplastic and non-neoplastic urothelial abnormalities.
    Casetta G; Piana P; Cavallini A; Vottero M; Tizzani A
    Br J Urol; 1993 Jul; 72(1):60-4. PubMed ID: 8149183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyfra 21-1 in monitoring cervical cancer: a comparison with tissue polypeptide antigen and squamous cell carcinoma antigen.
    Bonfrer JM; Gaarenstroom KN; Korse CM; Van Bunningen BN; Kenemans P
    Anticancer Res; 1997; 17(3C):2329-34. PubMed ID: 9245246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Can initial serum cyfra 21-1, SCC antigen, and TPA levels in squamous cell cervical cancer predict lymph node metastases or prognosis?
    Gaarenstroom KN; Kenter GG; Bonfrer JM; Korse CM; Van de Vijver MJ; Fleuren GJ; Trimbos JB
    Gynecol Oncol; 2000 Apr; 77(1):164-70. PubMed ID: 10739706
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intensive post-operative follow-up of breast cancer patients with tumour markers: CEA, TPA or CA15.3 vs MCA and MCA-CA15.3 vs CEA-TPA-CA15.3 panel in the early detection of distant metastases.
    Nicolini A; Tartarelli G; Carpi A; Metelli MR; Ferrari P; Anselmi L; Conte M; Berti P; Miccoli P
    BMC Cancer; 2006 Nov; 6():269. PubMed ID: 17116247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The clinical significance of serum tissue polypeptide antigen as a tumor marker for urogenital carcinomas--a comparison with other tumor markers in patients with renal cell carcinoma and prostatic carcinoma].
    Yamazaki K; Kumamoto Y; Tsukamoto T; Umehara T; Ohmura K
    Hinyokika Kiyo; 1987 Oct; 33(10):1581-9. PubMed ID: 2451408
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor-associated trypsin inhibitor as a prognostic factor during follow-up of bladder cancer.
    Kelloniemi E; Rintala E; Finne P; Stenman UH;
    Urology; 2003 Aug; 62(2):249-53. PubMed ID: 12893328
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Significance of combined determination of CK19mRNA, carcinoembryanic antigen, neuron-specific enolase, and tissue polypeptide antigen in peripheral blood of patients with lung cancer].
    Pan QR; Zhang X; Xu ZF; Zheng S
    Ai Zheng; 2002 Feb; 21(2):196-9. PubMed ID: 12479076
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Tissue polypeptide antigen in serum and tissue in patients with lung cancer].
    Haga E
    Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Apr; 28(4):595-604. PubMed ID: 2170727
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prospective evaluation of p53 as a prognostic marker in T1 transitional cell carcinoma of the bladder.
    Dalbagni G; Parekh DJ; Ben-Porat L; Potenzoni M; Herr HW; Reuter VE
    BJU Int; 2007 Feb; 99(2):281-5. PubMed ID: 17155984
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum TPS versus TPA in Egyptian bladder cancer patients.
    Halim AB; el-Ahmady O; Hamza S; Aboul-Ela M; Oehr P
    Int J Biol Markers; 1993; 8(4):221-6. PubMed ID: 7511149
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tissue polypeptide antigen and carcinoembryonic antigen as tumor markers in lung cancer.
    Lee YC; Yang PC; Kuo SH; Luh KT
    J Formos Med Assoc; 1991 Jul; 90(7):631-6. PubMed ID: 1681012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.